The company originated from Fudan University Science and Technology Development Company founded in 1984. It was restructured in 1992 and listed on the Shanghai Stock Exchange in January 1993. It is the first listed company in a Chinese university. In September 2020, in accordance with the central government's spirit of reform of enterprises belonging to colleges and universities, through the transfer of state-owned shares, the company became a state-owned listed company belonging to Fengxian District, and the actual controller was changed to the Fengxian District State-owned Assets Supervision and Administration Commission. The company's main business includes the three major business segments of pharmaceuticals, software, and parks. The company's main products are injectable glutathione, tamoxifen citrate tablets, flutamine tablets, bicalutamide tablets, carbamazepine tablets, taxerine tablets & capsules, injectable phentolamine mesylate, isosorbate nitrate tablets, clozoxazone tablets, cardiac and brain relief tablets, triptolide tablets, software and parks. Corporate honors include “Shanghai Famous Trademark”, “Key Software Enterprise within the National Planning Layout”, and the second prize of the Shanghai Science and Technology Progress Award.